Bridgeway Capital Management, LLC Mannkind Corp Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.84 - $1.76 $477,540 - $1 Million	-568,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $591,240 - $818,640	568,500 New	568,500 $711,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $421,830 - $727,560	-387,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $532,650 - $797,300	335,000 Added 644.23%	387,000 $735,000
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $118,559 - $197,600	52,000 New	52,000 $119,000

210

130M

1.81M

808K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.29B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.